|
|
Name: |
TCG Crossover Management LLC |
City: |
PALO ALTO |
State: |
CA |
Zip: |
94301 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
9 |
|
View All Holdings |
Currently
Viewing:
New Positions |
|
|
Page 1 of 1 |
Menu
|
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
CGON |
CG Oncology, Inc |
1 |
New |
$34.90 |
$156,732,000 |
3,570,206 |
12.39% |
156,732,000 |
3,570,206 |
5.409 |
N/A |
|
ATXS |
Astria Therapeutics, Inc |
3 |
New |
$8.87 |
$74,301,000 |
5,278,928 |
5.87% |
74,301,000 |
5,278,928 |
9.656 |
N/A |
|
KROS |
Keros Therapeutics, Inc. |
8 |
New |
$0.00 |
$58,213,000 |
879,344 |
4.6% |
58,213,000 |
879,344 |
2.588 |
N/A |
|
OCUL |
Ocular Therapeutix, Inc |
11 |
New |
$0.00 |
$48,404,000 |
5,319,148 |
3.83% |
48,404,000 |
5,319,148 |
4.826 |
N/A |
|
EWTX |
Edgewise Therapeutics, Inc. |
13 |
New |
$0.00 |
$41,455,000 |
2,272,728 |
3.28% |
41,455,000 |
2,272,728 |
2.463 |
N/A |
|
MLYS |
Mineralys Therapeutics, Inc. |
14 |
New |
$0.00 |
$41,121,000 |
3,185,185 |
3.25% |
41,121,000 |
3,185,185 |
7.795 |
N/A |
|
ADVM |
Adverum Biotechnologies, Inc |
21 |
New |
$7.45 |
$28,398,000 |
2,008,340 |
2.25% |
28,398,000 |
2,008,340 |
1.988 |
N/A |
|
SLNO |
Soleno Therapeutics Inc |
22 |
New |
$0.16 |
$23,540,000 |
550,000 |
1.86% |
23,540,000 |
550,000 |
0.691 |
N/A |
|
NKTR |
Nektar Therapeutics |
32 |
New |
$1.39 |
$3,737,000 |
4,000,000 |
0.3% |
3,737,000 |
4,000,000 |
2.23 |
Drug Delivery |
|